Top 50 Medical Device Startup Investors in Australia (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Artesian VC
VC Fund
|
21 | Australia, United States, China | Seed, Venture - Series Unknown, Pre-Seed | Software, Health Care, Artificial Intelligence | $40k–$17M |
|
Brandon Capital
VC Fund
|
8 | Australia, United Kingdom, United States | Series A, Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $673k–$81M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
6 | Australia, United States, United Kingdom | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $1.3M–$35M |
|
Melbourne Angels
VC Fund
|
6 | Australia, New Zealand, United States | Seed, Angel | Software, Information Technology, Biotechnology | $34k–$1.5M |
|
Breakthrough Victoria
VC Fund
|
5 | Australia, United States, Philippines | Seed, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $500k–$35M |
|
Brisbane Angels
VC Fund
|
5 | Australia, United States, New Zealand | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, Health Care | $120k–$2.8M |
|
Uniseed
VC Fund
|
5 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Manufacturing, Health Care | $566k–$22M |
|
Flying Fox Ventures
VC Fund
|
5 | Australia, New Zealand, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $120k–$11M |
|
Everywhere Ventures
VC Fund
|
4 | United States, United Kingdom, Australia | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $250k–$20M |
|
Sydney Angels
VC Fund
|
4 | Australia, United States | Seed, Angel, Pre-Seed | Software, SaaS, E-Commerce | $120k–$1.5M |
|
Significant Ventures
VC Fund
|
3 | Australia, United States | Seed, Series A | Manufacturing, Software, Health Care | $77k–$8.2M |
|
b2venture
VC Fund
|
3 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.2M–$52M |
|
Uniseed Ventures
VC Fund
|
2 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $381k–$94M |
|
CoAct Capital
VC Fund
|
2 | Australia, New Zealand | Series A, Seed, Series B | Software, Information Technology, SaaS | $4.4M–$14M |
|
Victoria University of Wellington
VC Fund
|
2 | Australia, New Zealand | Pre-Seed, Seed | Health Care, Medical, Therapeutics | |
|
Transition Level Investments
VC Fund
|
2 | Australia, United States, Colombia | Seed, Venture - Series Unknown, Series A | Software, Apps, Health Care | $168k–$16M |
|
Renew Pharmaceuticals
VC Fund
|
2 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | $5.6M–$6M |
|
Sprint Ventures
VC Fund
|
2 | Australia, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $655k–$10M |
|
Boson Ventures
VC Fund
|
2 | Australia | Seed, Pre-Seed, Series A | Financial Services, FinTech, Payments | $650k–$3M |
|
SFC Capital
VC Fund
|
2 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $123k–$2.5M |
|
Development Bank of Wales
VC Fund
|
2 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.5M |
|
Horizons Ventures
VC Fund
|
2 | United States, United Kingdom, Canada | Series A, Series B, Seed | Artificial Intelligence, Software, Biotechnology | $1M–$110M |
|
Sirius Capital
VC Fund
|
2 | China, Australia | Series A, Venture - Series Unknown, Seed | Artificial Intelligence, Robotics, Health Care | $1.4M–$50M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B, Venture - Series Unknown | Software, FinTech, Financial Services | $1.9M–$100M |
|
South Australian Venture Capital Fund
VC Fund
|
2 | Australia | Seed, Series B, Series A | Health Care, Biotechnology, Internet of Things | $1M–$26M |
|
Future of Healthcare Fund - Australian Unity
VC Fund
|
2 | Australia | Series A | Health Care, Medical Device, Medical | $3.4M–$6.6M |
|
Left Lane Capital
VC Fund
|
2 | United States, Germany, Canada | Series A, Series B, Seed | FinTech, Financial Services, Software | $2.5M–$100M |
|
Allan Moss
Angel
|
2 | Australia, United States, The Netherlands | Venture - Series Unknown, Series A, Seed | Health Care, Medical Device, Biotechnology | $2.3M–$25M |
|
Global Health Investment Fund (GHIF)
VC Fund
|
2 | United States, India, Austria | Series B, Series C, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $3.5M–$25M |
|
CP Ventures
VC Fund
|
2 | Australia, United States, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Machine Learning | $150k–$12M |
|
UniSA Ventures
VC Fund
|
2 | Australia | Seed, Pre-Seed | Software, Health Care, Biotechnology | |
|
Anova Capital
VC Fund
|
2 | China, Australia | Seed, Series A | Education, Rental, Travel | $1.5M–$4.6M |
|
Clare Ventures
VC Fund
|
2 | Australia | Series A | Health Care, Medical Device | $1.2M–$4.7M |
|
Fund WA
VC Fund
|
2 | Australia | Seed, Series A | Medical, Health Care, Manufacturing | |
|
AfterWork Ventures
VC Fund
|
1 | Australia, United States, New Zealand | Seed, Pre-Seed, Series A | Software, SaaS, FinTech | $367k–$21M |
|
Dexcom Ventures
VC Fund
|
1 | Australia | Sensor, Medical, Wearables | ||
|
Microsoft for Startups
VC Fund
|
1 | United States, India, Canada | Seed, Pre-Seed | Software, Information Technology, SaaS | |
|
Artesian Investment
Angel
|
1 | United States, India, Australia | Pre-Seed, Seed, Series A | Artificial Intelligence, Agriculture, Information Technology | |
|
Khosla Ventures
VC Fund
|
1 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
StreShi
VC Fund
|
1 | Australia, United States | Seed | Bitcoin, FinTech, Medical | |
|
Avicella Capital
VC Fund
|
1 | Australia | Series A, Series B | Therapeutics, Medical, Robotics | $3.1M–$25M |
|
PsyMed Ventures
VC Fund
|
1 | United States, Canada, Israel | Seed, Series A | Health Care, Biotechnology, Medical | $100k–$70M |
|
Sante Ventures
VC Fund
|
1 | United States, Canada, Japan | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.9M–$80M |
|
Right Click Capital
VC Fund
|
1 | Australia, Singapore, United States | Seed, Series A | Software, SaaS, Artificial Intelligence | $82k–$16M |
|
Versant Ventures
VC Fund
|
1 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5M–$107M |
|
Playford Capital
VC Fund
|
1 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
Andrew R Banks
Angel
|
1 | Australia | Seed | Grocery, Medical, Internet | $300k–$5M |
|
TEN13
VC Fund
|
1 | Australia, United States, Kenya | Seed, Series A, Pre-Seed | Software, SaaS, FinTech | $808k–$46M |
|
Starfish Ventures
VC Fund
|
1 | Australia, United States, Philippines | Series A, Series B | Software, Enterprise Software, Internet | $2M–$18M |
|
Ramsay Health Care
VC Fund
|
1 | Australia | Series A | Medical, Health Care, Medical Device | |
| Access all 217 investors in Australia Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Australia, United States, China
Investor stats
- Total investments: 640
- Round size: Seed $40k–$4.2M; Pre-Seed $42k–$553k; Venture - Series Unknown $650k–$17M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- TerraBlaster — TerraBlaster is a cutting-edge agricultural technology firm focused on transforming sustainable agriculture through enhanced automation and precise technologies.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 84
- Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Venture - Series Unknown $5.2M–$24M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $290M in 2025
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- Lumonus — Hello, we are Lumonus! We empower oncology care teams through software solutions and services.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.3M–$1.7M; Series A $1.3M–$13M; Venture - Series Unknown $4.3M–$35M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Melbourne Angels is the most active startup investor in Victoria, one of the most active in Australia. Investing in start-ups since 2007, Melbourne Angels is committed to helping innovative founders build the next generation of our economy.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Angel
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 73
- Round size: Seed $34k–$1.5M; Angel $200k–$918k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
- Mental Jam — We are a games studio dedicated to creating impactful experiences that explore mental health.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 111
- Round size: Seed $120k–$2.1M; Pre-Seed $200k–$1.4M; Venture - Series Unknown $543k–$2.8M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Indi — indi keeps every observation, document and reminder about your child organised in one place, ready to share with the clinicians and family supporting them.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
- Aussie colours —
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Care
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 93
- Round size: Seed $670k–$3.5M; Series A $1.6M–$16M; Series B $566k–$22M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $15M in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
- Facet Amtech — Facet Amtech develops and produces ammonia from water and air.
Flying Fox Ventures is an early stage investment firm that invests across industry and across the micro-stages of pre-seed and seed.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 112
- Round size: Seed $662k–$3.2M; Pre-Seed $120k–$3M; Series A $649k–$11M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Operata — Continuously measure performance to deliver the best possible customer experience.
- SPEC Toolbox — Structural timber design software for Australian engineers. Design CLT, GLT, and connections to AS1720 standards. Start your free trial and automate today.
- Teacher’s Buddy — Create lesson plans, worksheets, assessments, and more in minutes. AI-powered tools designed for educators.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Australia
Investor stats
- Total investments: 1304
- Round size: Seed $1M–$6.5M; Pre-Seed $250k–$2.5M; Series A $6M–$20M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely actively investing — fresh fund, raised $4.4M in 2026
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Noise — Noise makes finding UGC creators easy. Work smarter with personalized AI guidance to make your next UGC creator campaign go viral.
- Axo Longevity — Axo Longevity offers membership-based biomarker testing and digital health plans for preventive wellness and longevity optimization.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 99
- Round size: Seed $120k–$1.5M; Angel $130k–$1.1M; Pre-Seed $357k–$1.5M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 26
- Round size: Seed $77k–$4.8M; Series A $4.5M–$8.2M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
- Visionary Machines — Superior perception for next-generation autonomy
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 278
- Round size: Seed $1.2M–$8.8M; Series A $3.4M–$23M; Series B $6.9M–$52M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2026
Portfolio highlights
- LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
- Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
- Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.6M; Series A $1.3M–$16M; Series B $471k–$94M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro's Wi-Fi HaLow combines long-range, strong signal penetration, low power, and high throughput in one wireless protocol, delivering connectivity to more devices, at distance, with greater reliability.
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed, Series B
- Geography: Australia, New Zealand
Investor stats
- Total investments: 12
- Round size: Series A $4.4M–$14M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Veyor — The leading live scheduling app for the built environment, helping dispersed teams and their suppliers plan, manage and track daily activity on an easy to use mobile and desktop platform.
- OneReg — Designed specifically for Aviation - One powerful, integrated platform delivering full operational clarity, real-time compliance and smarter insights.
- EatClub — EatClub shows you nearby restaurants, with spare tables, offering last minute deals. Receive up to 50% off your bill (including drinks!)
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Pre-Seed, Seed
- Geography: Australia, New Zealand
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Avalia Immunotherapies — Avalia is developing #immunotherapies and #vaccines for the treatment and prevention of infectious diseases and cancer.
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Colombia
Investor stats
- Total investments: 35
- Round size: Seed $168k–$1.5M; Series A $1.1M–$16M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Picap — Picap is a Colombian ride-hailing service provider that connects people who require a means of transportation and people with motorcycles or cars who want to share their vehicle and earn additional income in the process. Founded in 2016, Picap operates in 13 cities including Bogotá, Medellín, Bucaramanga, Neiva, Villavicencio, Cartagena, Popayán,and Ibagué.
- Cafe X Technologies — Cafe X Technologies is focused on increasing productivity in the service industry through automation. Cafe X Technologies is a privately backed company with funding from Khosla Ventures, Social Capital, Jason Calacanis, Felicis Ventures, Silicon Valley Bank, and The Thiel Foundation.
Renew Pharmaceuticals is an healthcare company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Series A $5.6M–$6M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Early stage Venture Capital firm based in Brisbane that's investing in next generational Australian companies that are building a better future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 25
- Round size: Seed $655k–$2.4M; Series A $1.9M–$10M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- VAPAR — VAPAR offers CCTV pipe inspection software. The software is AI integrated for better results and accuracy. Prevent pipe failures and make informed pipe network decisions.
- Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Investor for disruptors and force carrier for impact! We are an Australian Venture Capital that backs visionary founders of all backgrounds and grows exceptional deep tech or business model innovation companies to become truly transformative!
Show more...Investment focus
- Industry: Financial Services, FinTech, Payments
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 11
- Round size: Seed $650k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AI-NC — Platform to connect engineers and manufacturers, and provide them with the right tools to streamline the process.
- Catalyser — Catalyser is customizable cloud software for better employee giving. It specializes in managing and growing employee giving in the workplace by volunteering, fundraising, payroll giving, appeals, and pro bono. the company involves in increasing employee engagement and social responsibility.
- Kite Magnetics — Electric motors enabling electric aircraft of all sizes to fly further, carry more and emit less. The future of aviation is electric.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 777
- Round size: Seed $123k–$2M; Pre-Seed $170k–$858k; Venture - Series Unknown $201k–$2.5M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
- Anemo Labs — We develop highly selective polymer-based sensors to detect gas VOCs in the ppb range, in real-time. We combine custom hardware with Machine Learning to characterize smells
- INTELLIGENT MASS SPEC SOLUTIONS — Intelligent Mass Spec Solutions develops urine-based mass spectrometry and machine learning diagnostics for adrenal cancer.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 294
- Round size: Seed $279k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.5M
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
- Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 344
- Round size: Seed $1M–$10M; Series A $5.8M–$42M; Series B $10M–$110M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
- Jobspotting — Jobspotting is a recommendations engine that suggests relevant jobs to users based on their skills and experience. The engine is powered by Skills Graph and Semantic Analysis technology. The company was founded in 2013 in Berlin, Germany by ex-Googlers Hessam Lavi, Jan Backes and Manuel Holtz. Robin Haak joined the founding team in 2014 aftermeeting them through the Axel Springer Plug and Play Accelerator Programme, of which he was a co-founder. Jobspotting successfully acquired seed funding.
- Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
Sirius Capital is a venture capital firm in China that invests in technology companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Health Care
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: China, Australia
Investor stats
- Total investments: 16
- Round size: Seed $1.4M–$4.6M; Series A $7M–$50M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Vantari VR — Virtual Reality for Healthcare
- Zenbot — Zenbot is a high-growth startup specializing in embodied intelligence infrastructure.
- Kuanfen Technology Realcome — Kuanfen Technology Realcome is a brand of AI virtual bloggers that focuses on the use of various AI technologies.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Convertible Note, Series B, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 85
- Round size: Series B $7M–$30M; Convertible Note $1.9M–$18M; Venture - Series Unknown $4M–$100M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $52M in 2022
Portfolio highlights
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Firmus Technologies — Building the cloud infrastructure of tomorrow, today.
- Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet of Things
- Stage:Seed, Series B, Series A
- Geography: Australia
Investor stats
- Total investments: 14
- Round size: Seed $1M–$12M; Series A $2.3M–$20M; Series B $13M–$26M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Seonix Bio — Seonix Bio aims to improve the treatment and prevention of blinding eye disease by developing advanced risk prediction tools.
- Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Series A $3.4M–$6.6M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Left Lane Capital is a venture capital and seed-growth equity firm that invests in high-growth internet and consumer technology businesses that are fundamental to the human condition and spirit – where customers maintain a long-term relationship with the product, platform, or service.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 180
- Round size: Seed $2.5M–$20M; Series A $9.4M–$37M; Series B $23M–$100M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $1.4B in 2022
Portfolio highlights
- Evvy — Evvy is a developer of at-home vaginal microbiome tests to close the gender health gap and improve female health. It uses metagenomic sequencing to understand symptoms and risks for critical health challenges, and get personalized reports.
- HIFI — HIFI is a next-generation payments infrastructure platform. The company powers a suite of modern payment APIs to enable businesses to move money faster on a global scale for the next chapter of the internet. Our payment rails powers businesses to move money instantly with near-zero cost to enhance cash flow, reduce inefficiencies, increasevisibility, and combat fraud.Zach Walsh and Mohamed Afifi founded the company in New York City in 2022.
- Rising Tide — Rising Tide provides tech and capital to scale independent property managers.
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Australia, United States, The Netherlands
Investor stats
- Total investments: 9
- Round size: Series A $2.3M–$8.8M; Venture - Series Unknown $3.5M–$25M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — From inspection to insight. We build the Physical AI layer for industrial asset integrity. Get repeatable, decision-ready data and asset life analytics - without confined space entry
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series B, Series C, Venture - Series Unknown
- Geography: United States, India, Austria
Investor stats
- Total investments: 21
- Round size: Series B $7.5M–$19M; Series C $4.5M–$14M; Venture - Series Unknown $3.5M–$25M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $108M in 2012
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
CP Ventures is a boutique, high-performance global venture capital firm backing breakthrough 4th Industrial Revolution technologies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, India
Investor stats
- Total investments: 91
- Round size: Seed $482k–$4.2M; Pre-Seed $150k–$900k; Series A $3.8M–$12M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
- Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
- Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $31M in 2019
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Anova Capital focus on investment in education, big health and new consumption.
Show more...Investment focus
- Industry: Education, Rental, Travel
- Stage:Seed, Series A
- Geography: China, Australia
Investor stats
- Total investments: 4
- Round size: Seed $1.5M–$4.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Qukoucai — Qukoucai is an online interactive learning platform for children and children. It focuses on providing customized online personal eloquence courses for 4-12 years old children. It includes a complete closed-loop product of teaching, practice, evaluation and display, and is committed to improving children's eloquence. ability.
- Vantari VR — Virtual Reality for Healthcare
- Woody Library — Woody Library is the first subscription-based book sharing and rental platform in China. In the cabin, you can spend the least amount of money, read the most books, and never again, the book that bought the hand has turned over a few pages and found that it has no long-term collection value.
Clare Ventures provides the capital female-founded businesses deserve to innovate, scale and create lasting impact.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Series A $1.2M–$4.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 12
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Enzide — Enzide is an Australian company solving plastic pollution with new super enzyme technology based on years of research
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
We are a community-powered VC fund making pre-seed / seed stage investments in Australian and New Zealand startups. Our community is rallied around a shared goal: to invest in the next generation of Australia and New Zealand startups at the very earliest stage, and then support them on their long a
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 83
- Round size: Seed $367k–$2.5M; Pre-Seed $410k–$2.2M; Series A $4.2M–$21M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- BarterAds Pty Ltd — BarterAds is a programmatic advertising exchange that enables businesses to acquire customers without cash spend by converting unused ad inventory into a tradable asset. Instead of paying in fiat, companies earn and spend a proprietary internal currency called Barter Dollars, which are issued when they display ads on their owned media propertiessuch as websites, apps, or platforms.The platform operates as an auction-based exchange, similar to traditional ad networks, where advertisers bid for impressions using Barter Dollars. Inventory is matched contextually and priced dynamically through real-time bidding, ensuring efficient allocation of supply and demand across the network. This allows both advertisers and publishers to maximize the value of otherwise underutilized inventory.BarterAds primarily targets startups, SaaS platforms, marketplaces, gaming companies, and content publishers that have traffic but are constrained by rising customer acquisition costs. By removing the need for upfront cash spend, the platform provides a capital-efficient growth channel, particularly for small and mid-sized businesses.The system includes controls for brand safety, fraud prevention, and inventory quality through business verification, campaign approvals, and continuous monitoring. Barter Dollars are non-transferable and expire periodically, preventing hoarding and ensuring continuous circulation within the ecosystem.BarterAds is designed as a hybrid between barter networks and modern ad exchanges, combining the scalability and automation of programmatic advertising with a closed-loop, cashless economy. The company is headquartered in Australia and is focused on building a global network of advertisers and publishers who both contribute inventory and run campaigns within the platform.
- Samphire Neuroscience — Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.
The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.
Show more...Investment focus
- Industry: Sensor, Medical, Wearables
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: United States, India, Canada
Investor stats
- Total investments: 71
- Lead/follow: no public data
Portfolio highlights
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- UniPay — UniPay is an eCommerce platform for infrastructure and industry-lacking regions that offers 5 products that enable trust, promote transparency, and enforce accountability.
- Emission Sentri — Drive emission management and reduction with insights
Artesian Investment
Show more...Investment focus
- Industry: Artificial Intelligence, Agriculture, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, India, Australia
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
- LYRO Robotics — A robotic packing solution for fruits and vegetables
- HUVIAiR Technologies — A full-stack construction management tool designed for executive leadership. Deliver projects faster, improve build quality and reduce project costs.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1085
- Round size: Seed $2M–$17M; Series A $5.5M–$44M; Series B $10M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $557M in 2022
Portfolio highlights
- Fundbox — Fundbox offers fast, easy access to business financing, up to $150,000. Learn how our line of credit and term loan options can unlock growth for your business.
- Even — Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
- Loop — Loop Health is bringing ease and choice to patients seeking major medical treatments. We've brought together family physicians, top specialists, and leading hospitals in Pune – to provide options, transparency, and ease to patients and their families. Loop Coordinators help patients match with a doctor, compare treatment costs, get secondopinions, and complete admission formalities – removing the stress and making lives easier for the patient and their families.
Progressive Technology To The People
Show more...Investment focus
- Industry: Bitcoin, FinTech, Medical
- Stage:Seed
- Geography: Australia, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neurode — Drug free, non-invasive treatment of ADHD
- Purse — The biggest challenge to Bitcoin commerce is the lack of consumer incentive to spend. Purse generates this incentive in the form of 15% discounts on Amazon. Buyers can purchase bitcoins with a credit card as easily as checking out on Amazon, thus solving the last mile problem.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Avicella Capital is to identify and finance commercial ventures that ethical and creative entrepreneurs have created to enhance patient outcomes and raise the standard of healthcare.
Show more...Investment focus
- Industry: Therapeutics, Medical, Robotics
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Series A $3.1M–$25M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Faeth Therapeutics — Home | Faeth
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
- Convergence Medical Robotics — Convergence Medical Robotics is a Brisbane-based pre-clinical medical robotics company making arthroscopy better through the invention of the V01 Robot. It solves the complexity of arthroscopy by creating the world's first arthroscopic robot.
We are a community focused fund and syndicate investing in frontier mental health: psychedelics, neurotech, precision psychiatry, digital therapeutics, holistic medicine, metabolic psychiatry, digital health, and artificial intelligence.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 24
- Round size: Seed $100k–$21M; Series A $4.8M–$70M
- Lead/follow: 0% lead, 100% follow
- Last fund: Likely still investing — raised $25M in 2022
Portfolio highlights
- Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
- Sanmai — Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders
- Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
Privately Held Companies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Japan
Investor stats
- Total investments: 115
- Round size: Series A $1.9M–$32M; Series B $2.6M–$61M; Series C $5M–$80M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $260M in 2021
Portfolio highlights
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
- SONIRE Therapeutics — SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd..
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Right Click Capital - Australian Venture Capital Firm
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Australia, Singapore, United States
Investor stats
- Total investments: 81
- Round size: Seed $82k–$3M; Series A $3.1M–$16M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 333
- Round size: Series A $5M–$78M; Series B $12M–$105M; Series C $12M–$107M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $5M in 2024
Portfolio highlights
- Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
- Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
- Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Andrew R Banks currently works as the Executive Chairman for The Veneto Group Pty Lt. He Previously worked at Talent2 as the Founder ,Chairman and Managing Director. Andrew R Banks attended Harvard Business School in 2009.
Show more...Investment focus
- Industry: Grocery, Medical, Internet
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Seed $300k–$5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
- Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.
- Compono — Smart, easy-to-use HR management products for sourcing talent and helping them grow.
TEN13 is Australia's leading Venture Capital Syndicate.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Kenya
Investor stats
- Total investments: 85
- Round size: Seed $999k–$8M; Pre-Seed $808k–$2.2M; Series A $3.7M–$46M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Flyweel — Flyweel is agentic fintech for businesses that depend on ads for their growth. It connects spend, cash, and revenue, then acts on them in real time, shifting budget to the ads that work, drawing capital when the numbers justify it, and easing off when cash runs low, all without anyone in the loop.
- Appetise — MenuAid is a cheaper, flexible and more sustainable alternative to meal-kit delivery providers. We provide Kiwis with a weekly meal plan, complete with recipes and a list of ingredients that can either be self-shopped or collected/delivered from your favourite supermarkets.
- Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 59
- Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $162M in 2008
Portfolio highlights
- CAP-XX — CAP-XX makes ultra-thin, high-power supercapacitors for portable and compact devices. Ideal for energy storage. Quotes & samples available.
- Ourcast — Ourcast Inc. has a mobile app that it says can accurately predict precipitation during the next two hours.
- Smart Urban Properties Australia (SUPA) — Smart Urban Properties Australia (SUPA) offers a unique range of property solutions by bringing together renewable energy and mobility, super-speed fiber, and smart prop-tech. It is formed by bringing together Epsilon Security, b.energy, Fibrecorp, Smart Automation Systems, and connecX.
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Medical Device Investor funding in Australia at a glance
Stats across 253 deals from 217 investors.
Access all 217 investors in Australia Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 217 investors investing in Australia Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!